Smital Shah is Chief Business and Financial Officer at ProQR Therapeutics, where she is responsible for finance, investor relations and communications, business development and commercial. She has 20 years of experience in management and leadership roles in biopharma companies and investment banking. Smital has a Bachelor’s and Master’s in chemical engineering and an MBA from the University of California at Berkeley. Smital is currently a board member at Pliant Therapeutics.